NCT02182024View on ClinicalTrials.gov

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2006

Conditions
Renal Insufficiency
Interventions
DRUG

Dabigatran etexilate high dose

DRUG

Dabigatran etexilate low dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY